LabGenius is a Biotech company based in London, United Kingdom. It has raised $75M in total funding. Latest round: Series A.
LabGenius funding overview
LabGenius is a Biotech company based in London, United Kingdom. LabGenius has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2019. The round record for LabGenius runs through 2019; nothing later has been disclosed. Investors on record include Atomico, Lux Capital, Obvious Ventures, Felicis. 4 distinct backers are named across the disclosed rounds.
LabGenius at a glance
Total raised
$75M
Latest round
Series A
Latest round date
October 2019
Industry
Biotech
Headquarters
London, United Kingdom
Notable investors
Atomico, Lux Capital, Obvious Ventures, Felicis
Frequently asked about LabGenius funding
How much has LabGenius raised?
LabGenius has raised $75M in total disclosed funding across the rounds on record.
Who has invested in LabGenius?
Atomico, Lux Capital, Obvious Ventures, Felicis are named among the investors backing LabGenius.
What was the latest LabGenius funding round?
The most recent disclosed round is a Series A, announced in October 2019.
Where is LabGenius based?
LabGenius is based in London, United Kingdom.
What sector does LabGenius operate in?
LabGenius is tracked under Biotech from London, United Kingdom, with $75M in disclosed funding.
When did LabGenius last raise?
The last disclosed LabGenius round closed in October 2019 at Series A.
Round data for LabGenius is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in London and backer lists below.
